Recherche
Résultats 1-7 de 7
-
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular b-cell lymphoma (galen): a multicentre, single-arm, phase 2 study
The Lancet. Haematology, 08-07-2019Article dans une revue scientifique -
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-hodgkin lymphoma: final results from a phase 2 randomised study (romulus)
The Lancet. Haematology, 29-03-2019Article dans une revue scientifique -
On-target pharmacodynamic activity of the pi3k inhibitor copanlisib in paired biopsies from patients with malignant lymphoma and advanced solid tumors
Molecular cancer therapeutics, 16-10-2019Article dans une revue scientifique -
Long-term fatigue in survivors of non-hodgkin lymphoma: the lymphoma study association simonal cross-sectional study
Cancer, 22-03-2019Article dans une revue scientifique -
Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large b-cell lymphoma: an open-label, non-randomised, phase 1b-2 study
The Lancet. Oncology, 14-05-2019Article dans une revue scientifique -
Venetoclax plus r- or g-chop in non-hodgkin lymphoma: results from the cavalli phase 1b trial
Blood, 08-03-2019Article dans une revue scientifique -
Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059)
Leukemia, Springer Nature, 11-12-2019, 34 (5), pages 1458–1461Article dans une revue scientifiquetexte intégral